SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Revisions to previously issued financial statements) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Net loss | $ (5,383,973) | $ (5,383,973) | $ (5,383,973) | $ (0) |
| Income Tax Expense (Benefit) | 5,383,973 | 5,383,973 | 5,383,973 | 0 |
| Net loss | $ 29,171,328 | $ 35,531,655 | $ 150,052,486 | $ 45,510,309 |
| Earnings Per Share, Basic | $ (0.8) | $ (2.85) | $ (8.12) | $ (1,175.22) |
| Earnings Per Share, Diluted | $ (0.8) | $ (2.85) | $ (8.12) | $ (1,175.22) |
| Net loss | $ (29,171,328) | $ (35,531,655) | $ (150,052,486) | $ (45,510,309) |
| Proceeds from issuance of common stock and pre-funded warrants | 474,907,637 | |||
| Net cash provided by financing activities | (5,383,973) | 478,370,526 | 10,373,092 | |
| Additional paid-in capital | 678,894,847 | 678,894,847 | 681,864,757 | 166,357,208 |
| Accumulated deficit | (201,848,102) | (201,848,102) | $ (316,368,933) | $ (166,316,447) |
| July 2025 Private Placement [Member] | ||||
| Proceeds from issuance of common stock and pre-funded warrants | 0 | |||
| Previously Reported [Member] | ||||
| Net loss | 0 | 0 | ||
| Income Tax Expense (Benefit) | 0 | 0 | ||
| Net loss | $ 34,555,301 | $ 40,915,628 | ||
| Earnings Per Share, Basic | $ (0.96) | $ (3.28) | ||
| Earnings Per Share, Diluted | $ (0.96) | $ (3.28) | ||
| Net loss | $ (34,555,301) | $ (40,915,628) | ||
| Proceeds from issuance of common stock and pre-funded warrants | 480,291,610 | |||
| Net cash provided by financing activities | 0 | |||
| Additional paid-in capital | 684,278,820 | 684,278,820 | ||
| Accumulated deficit | $ (207,232,075) | (207,232,075) | ||
| Previously Reported [Member] | July 2025 Private Placement [Member] | ||||
| Proceeds from issuance of common stock and pre-funded warrants | $ 0 | |||
| X | ||||||||||
- Definition Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|